|
VDAC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.196610E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.387800E-02 |
| Normal-vs-Stage2 |
9.082800E-01 |
| Normal-vs-Stage3 |
6.458000E-01 |
| Normal-vs-Stage4 |
1.703410E-01 |
| Stage1-vs-Stage2 |
3.985000E-01 |
| Stage1-vs-Stage3 |
1.935580E-01 |
| Stage1-vs-Stage4 |
2.397700E-02 |
| Stage2-vs-Stage3 |
7.909600E-01 |
| Stage2-vs-Stage4 |
1.590040E-01 |
| Stage3-vs-Stage4 |
2.698200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.457900E-02 |
| Normal-vs-AfricanAmerican |
5.843200E-01 |
| Normal-vs-Asian |
4.880600E-01 |
| Caucasian-vs-AfricanAmerican |
5.529800E-01 |
| Caucasian-vs-Asian |
3.886600E-01 |
| AfricanAmerican-vs-Asian |
4.445800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.088300E-02 |
| Normal-vs-Female |
7.350400E-01 |
| Male-vs-Female |
3.645000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.476200E-01 |
| Normal-vs-Extreme_Weight |
1.402220E-01 |
| Normal-vs-Obese |
6.565800E-02 |
| Normal-vs-Extreme_Obese |
9.213400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.859000E-01 |
| Normal_Weight-vs-Obese |
4.028400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.209200E-01 |
| Extreme_Weight-vs-Obese |
7.115600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.715000E-01 |
| Obese-vs-Extreme_Obese |
5.375000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.344400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.822200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.766770E-01 |
| Normal-vs-Age(81-100Yrs) |
5.947000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.554400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.958400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.906200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.196000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.849000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.979390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.70690000000207E-05 |
| Normal-VS-Type2 PRCC |
7.357300E-03 |
| Normal-VS-KIRP CIMP |
1.486420E-01 |
| Normal-VS-Unclassified PRCC |
1.842970E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.02840000004711E-06 |
| Type1 PRCC-VS-KIRP CIMP |
8.253600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.358800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.132100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.798840E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.753800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.697800E-01 |
| Normal-vs-N1 |
7.936200E-01 |
| Normal-vs-N2 |
8.416600E-01 |
| N0-vs-N1 |
4.432600E-01 |
| N0-vs-N2 |
9.351800E-01 |
| N1-vs-N2 |
7.853400E-01 |
|
|
